Ramon Luengo-Fernandez

• Time Course of Evolution of Disability and Cause-Specific Mortality After Ischemic Stroke: Implications for Trial Design.

  Ganesh A. et al, (2017), J Am Heart Assoc, 6

• Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.

  Olfert JA. et al, (2017), Respirology, 22, 764 - 770

• Economic burden of non-malignant blood disorders across Europe: a population-based cost study.

  Luengo-Fernandez R. et al, (2016), Lancet Haematol, 3, e371 - e378

• Economic burden of malignant blood disorders across Europe: a population-based cost analysis.

  Burns R. et al, (2016), Lancet Haematol, 3, e362 - e370

• Cost-utility analysis of stenting versus endarterectomy in the International Carotid Stenting Study.

  Morris S. et al, (2016), Int J Stroke, 11, 446 - 453

• Economic Burden of Bladder Cancer Across the European Union.

  Leal J. et al, (2016), Eur Urol, 69, 438 - 447

• Temperature-controlled laminar airflow in severe asthma for exacerbation reduction (The LASER Trial): study protocol for a randomised controlled trial.

  Storrar W. et al, (2016), Trials, 17

• Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial.

  Freeman D. et al, (2015), Lancet Psychiatry, 2, 975 - 983

• Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.

  Scanlon PH. et al, (2015), Health Technol Assess, 19, 1 - 116

• UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia.

  Luengo-Fernandez R. et al, (2015), BMJ Open, 5

• Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study.

  Yiin GS. et al, (2014), Circulation, 130, 1236 - 1244

• Economic burden of cancer across the European Union: a population-based cost analysis.

  Luengo-Fernandez R. et al, (2013), Lancet Oncol, 14, 1165 - 1174

• Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study.

  Luengo-Fernandez R. et al, (2013), Neurology, 81, 1588 - 1595

• Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the oxford vascular study

  Luengo-Fernandez R. et al, (2013), Stroke, 44, 2854 - 2861

• Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study.

  Luengo-Fernandez R. et al, (2013), Stroke, 44, 2854 - 2861

• The effects of using cognitive behavioural therapy to improve sleep for patients with delusions and hallucinations (the BEST study): study protocol for a randomized controlled trial.

  Freeman D. et al, (2013), Trials, 14

• Population-based study of acute- and long-term care costs after stroke in patients with AF.

  Luengo-Fernandez R. et al, (2013), Int J Stroke, 8, 308 - 314

• Hospitalization resource use and costs before and after TIA and stroke: results from a population-based cohort study (OXVASC).

  Luengo-Fernandez R. et al, (2013), Value Health, 16, 280 - 287

• Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: a population-based study.

  Paul NL. et al, (2013), J Neurol Neurosurg Psychiatry, 84, 356 - 361

• A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke

  Luengo-Fernandez R. et al, (2012), Stroke, 43, 3343 - 3351

• UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?

  Luengo-Fernandez R. et al, (2012), Eur J Neurol, 19, 149 - 154

• Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: A population-based study

  Paul NLM. et al, (2012), Journal of Neurology, Neurosurgery and Psychiatry

• [Economic evaluation of healthcare technologies: an introduction for physicians].

  Luengo-Fernández R. et al, (2011), Rev Neurol, 53, 107 - 115

• Cost of dementia in the pre-enlargement countries of the European Union.

  Luengo-Fernandez R. et al, (2011), J Alzheimers Dis, 27, 187 - 196

• Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.

  Rivero-Arias O. et al, (2010), Med Decis Making, 30, 341 - 354

• ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack.

  Chandratheva A. et al, (2010), Stroke, 41, 851 - 856

• Independent validation of the prolonged length of stay score.

  Koton S. et al, (2010), Neuroepidemiology, 35, 263 - 266

• Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison.

  Luengo-Fernandez R. et al, (2009), Lancet Neurol, 8, 235 - 243

• Costs of stroke using patient-level data: a critical review of the literature.

  Luengo-Fernandez R. et al, (2009), Stroke, 40, e18 - e23

• Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom.

  Luengo-Fernandez R. et al, (2006), Stroke, 37, 2579 - 2587

• Cost of cardiovascular diseases in the United Kingdom.

  Luengo-Fernández R. et al, (2006), Heart, 92, 1384 - 1389

• Economic evaluation. Part 2: frameworks for combining costs and benefits in health care.

  McIntosh E. and Luengo-Fernandez R., (2006), J Fam Plann Reprod Health Care, 32, 176 - 180

• Economic burden of cardiovascular diseases in the enlarged European Union.

  Leal J. et al, (2006), Eur Heart J, 27, 1610 - 1619

• Economic burden of cardiovascular disease in the enlarged European Union

  Leal J. et al, (2006), Revista Portuguesa de Cardiologia, 25, 663 - 665

• Economic evaluation. Part 1: Introduction to the concepts of economic evaluation in health care.

  McIntosh E. and Luengo-Fernandez R., (2006), J Fam Plann Reprod Health Care, 32, 107 - 112

• Acute costs of stroke in the UK National Health Service in 2002-2004

  Luengo-Fernandez R. et al, (2004), VALUE IN HEALTH, 7, 692 - 692

Recent Publications

• Time Course of Evolution of Disability and Cause-Specific Mortality After Ischemic Stroke: Implications for Trial Design.

  Ganesh A. et al, (2017), J Am Heart Assoc, 6

• Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.

  Olfert JA. et al, (2017), Respirology, 22, 764 - 770

• Economic burden of non-malignant blood disorders across Europe: a population-based cost study.

  Luengo-Fernandez R. et al, (2016), Lancet Haematol, 3, e371 - e378

• Economic burden of malignant blood disorders across Europe: a population-based cost analysis.

  Burns R. et al, (2016), Lancet Haematol, 3, e362 - e370

• Cost-utility analysis of stenting versus endarterectomy in the International Carotid Stenting Study.

  Morris S. et al, (2016), Int J Stroke, 11, 446 - 453